Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T Krivasi
Prm162 - A Piecewise Approach to the Extrapolation of Invasive Disease-Free Survival (Idfs) in the Adjuvant Treatment of Her2+ Breast Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Mapping From SF-36 Trial Data to EQ-5D Utilities in Advanced Basal Cell Carcinoma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Adjuvant Treatment of HER2-positive Breast Cancer: Winning Efforts Continue to Improve HER2-positive Patient Outcome Long-Term
Breast Cancer Research
Cancer Research
Oncology
A miRNA-based Signature Predicts Development of Disease Recurrence in HER2 Positive Breast Cancer After Adjuvant Trastuzumab-Based Treatment
Scientific Reports
Multidisciplinary
Factors Affecting Distant Disease-Free Survival for Primary Invasive Breast Cancer: Use of a Log-Normal Survival Model
Annals of Surgical Oncology
Oncology
Surgery
The Analysis of Relapse-Free Survival Curves: Implications for Evaluating Intensive Systemic Adjuvant Treatment Regimens for Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
Neratinib in Adjuvant Treatment of Patients With HER2-positive Breast Cancer — Less Is More?
Oncology in Clinical Practice
Oncology
Cyclin D3 Predicts Disease-Free Survival in Breast Cancer
Cancer Cell International
Cancer Research
Oncology
Genetics
New Developments in the Treatment of HER2-positive Breast Cancer
Breast Cancer: Targets and Therapy
Oncology
A Case-Control Study of the HER2 Ile655Val Polymorphism in Relation to Risk of Invasive Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
Retrospective Analysis of HER2 Therapy Interruption in Patients Responding to the Treatment in Metastatic HER2+ Breast Cancer
ESMO Open
Cancer Research
Oncology
